Moderna to seek emergency FDA authorization for coronavirus vaccine

Moderna will file Monday for an emergency authorization of its coronavirus vaccine from the Food and Drug Administration, becoming the second company to do so.

The vaccine developer said it would simultaneously ask the European Medicines Agency for conditional approval.

The FDA filing would clear the way for the vaccine to be authorized for use in the United States within weeks. Moderna's application relies on a final analysis of its 30,000-person late-stage trial that showed the vaccine to have 94.1 percent efficacy, on par with the 94.5 percent reported in...